Found 7 matching trials
NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers
PHASE1This is the second clinical study of NOX-A12. This study intends to provide...
Location
Charité Research Organisation GmbH
NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma
PHASE2The purpose of this study is to evaluate the safety and efficacy of NOX A12...
Location
University Hospital Salzburg, Department of Medicine III, Center of Oncology and Hematology
Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer
PHASE1The purpose of this study is to show that the type, number and/or distribut...
Location
Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
NOX-A12 First-in-human (FIH) Study
PHASE1This is the first time NOX-A12 will be administered to man. The principal a...
Location
Scope Life Sciences GmbH
NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)
PHASE2The purpose of this study is to evaluate the safety and efficacy of NOX A12...
Location
Medical University Innsbruck, Division of Hematology and Oncology
Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
PHASE1The purpose of this study is to obtain first, exploratory information on th...
Status
Active Not Recruiting
Location
Klinik und Poliklinik für Neurologie Schwerpunkt Klinische Neuroonkologie
Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer
PHASE2The purpose of this study is to provide a go/no-go decision for a randomize...
Location
Multiple Locations